A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
Status:
Recruiting
Trial end date:
2023-07-06
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the efficacy (using the modified Friedreich
Ataxia Rating Scale [mFARS]) and safety of vatiquinone in participants with Friedreich ataxia
(FA).